American Century Companies’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SGTX
FP
HP
AG
American Century Companies's SGTX Position: Q4 2021 in Review
American Century Companies sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q4 2021, closing a stake of 27,668 shares — an estimated $2.03M sold.
American Century Companies first reported a position in SGTX in Q4 2020 and held it in 4 quarters. The position peaked at $6.94M in Q4 2020. 50 funds tracked by Wall St. Rank hold SGTX as of Q4 2021.
- American Century Companies reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
- American Century Companies sold 27,668 Sigilon Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $2.03M.
- American Century Companies first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
- American Century Companies's Sigilon Therapeutics, Inc. Common Stock position peaked at $6.94M in Q4 2020.
- 50 funds tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q4 2021.
Based on American Century Companies's 13F filing for Q4 2021, filed 7 Feb 2022.